Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P13
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -261.90% |
| Q3 2025 | 65.57% |
| Q2 2025 | -64.86% |
| Q1 2025 | -94.74% |
| Q4 2024 | 60.42% |
| Q3 2024 | -65.52% |
| Q2 2024 | 35.56% |
| Q1 2024 | 89.53% |
| Q4 2023 | -877.27% |
| Q3 2023 | -15.79% |
| Q2 2023 | 26.92% |
| Q1 2023 | 35.00% |
| Q4 2022 | -1433.33% |
| Q3 2022 | -84.21% |
| Q2 2022 | -92.53% |
| Q1 2022 | 46.26% |
| Q4 2021 | -15.74% |
| Q3 2021 | 50.73% |
| Q2 2021 | -60.63% |
| Q1 2021 | 6.26% |
| Q4 2020 | 210.43% |
| Q3 2020 | 1306.67% |
| Q2 2020 | 265.38% |
| Q1 2020 | -504.67% |
| Q4 2019 | -118.75% |
| Q3 2019 | 300.00% |
| Q2 2019 | 120.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | -51.52% |
| Q3 2018 | 45.00% |
| Q2 2018 | 45.45% |
| Q1 2018 | -10.00% |
| Q4 2017 | -66.67% |
| Q3 2017 | -4185.71% |
| Q2 2017 | -114.00% |
| Q1 2017 | -80.00% |
| Q4 2016 | 183.06% |
| Q3 2016 | 87.19% |
| Q2 2016 | -1005.88% |
| Q1 2016 | 93.66% |